COMMUNIQUÉS West-GlobeNewswire

Elizabeth Holmes Is in Prison But 'Theranos 2.0' Just Hit the Market
16/06/2025
“You Cannot Silence the Science,” Says Theranos and Blue Magic Inventor PALM BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- Elizabeth Holmes may be behind bars, but the vision she once promoted, a world where blood [...]
NOTICE TO DISREGARD -- Ministry of Health Saudi Arabia
16/06/2025
BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- We are advised by Ministry of Health Saudi Arabia that journalists and other readers should disregard the news release, "Saudia Arabia Introduces Strategic Healthcare Vision and [...]
VitalHub Files Preliminary Base Shelf Prospectus
16/06/2025
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announces that today it has filed and obtained a receipt for a preliminary short form base shelf [...]
Finnish Australian Venture Agora Launches Personalized AI Doctors
17/06/2025
Female-led startup introduces Build Your Own Doc, turning preventive wellness into a data-driven gamified experience Helsinki, Finland, June 16, 2025 (GLOBE NEWSWIRE) -- Finnish-Australian health technology company [...]
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results
17/06/2025
FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025. Financial Highlights [...]
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
16/06/2025
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based cannabinoids, wishes to [...]
The Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion Therapy
16/06/2025
TUCSON, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) filed its amicus brief in the U.S. Supreme Court on June 12 against a Colorado ban on conversion therapy for [...]
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 €
16/06/2025
L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies humaines MONTRÉAL, 16 juin 2025 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex , une organisation fondée par [...]
Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 research grant
16/06/2025
The objective is to advance microbiota’s role study in human health & diseases MONTREAL, June 16, 2025 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and dedicated to [...]
Transactions in Connection with Share Buy-back Program
16/06/2025
Company Announcement COPENHAGEN, Denmark; June 16, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce [...]
Inquis Medical’s AVENTUS Thrombectomy System Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism
16/06/2025
Pioneering device combines precision clot removal with autologous blood reinfusion to address unmet needs in PE treatment MENLO PARK, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Inquis Medical , the leading innovator in [...]
BioAro Launches PanOmiQ™ Research in Breakthrough for AI-Driven Drug Discovery and Multi-Omics
16/06/2025
AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery. PanOmiQ™ Research sets a new global benchmark for precision health innovation. BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- BIO [...]
FibroBiologics to Present at the BIO International Convention 2025
16/06/2025
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of [...]
Procès-verbal de l'Assemblée Générale Ordinaire d'IBA et résultats des votes
16/06/2025
Information réglementée Assemblée Générale Ordinaire du 11 juin 2025 Belgique, le 16 juin 2025 ( 17h50 ) – Ion Beam Applications SA (« IBA ») annonce que l’ensemble des résolutions proposées à ses actionnaires lors de l [...]
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
16/06/2025
NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares [...]
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI
16/06/2025
—Data across pediatric, adolescent, and adult populations demonstrate sustained reductions in HAE attacks and consistent safety profile— —Patients report improved quality of life and daily functioning with ORLADEYO— [...]
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
16/06/2025
BEDFORD, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced [...]
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
16/06/2025
Proposed acquisition expected to accelerate mid- to long-term revenue and cash flow growth and further diversify revenue base. Strengthens Supernus’ leading presence in neuropsychiatric conditions with an innovative [...]
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 85th Scientific Sessions
16/06/2025
– Hengrui to present six abstracts highlighting clinical progress of GLP-1/GIP dual receptor agonist HRS9531 (KAI-9531) and GLP-1 receptor agonist HRS-7535 (KAI-7535) in type 2 diabetes and obesity – JIANGSU, China and [...]

Pages